Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Klebsiella Pneumoniae Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Klebsiella pneumoniae infections markets are expected to exhibit a CAGR of 4.78% during 2024-2034. The Klebsiella pneumoniae infections market has been comprehensively analyzed in IMARC's...

May 2024 137 pages

Klinefelter Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Klinefelter syndrome markets are expected to exhibit a CAGR of 3.39% during 2024-2034. The Klinefelter syndrome market has been comprehensively analyzed in IMARC's new report titled 'Kline...

May 2024 136 pages

Knee Osteoarthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major knee osteoarthritis markets reached a value of US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.1 Billion by 2034, exhibiting a growth rate (CAGR) of 6....

May 2024 133 pages

Kounis Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Kounis syndrome markets reached a value of US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.81%...

May 2024 138 pages

Krabbe Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Krabbe disease markets reached a value of US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.81% d...

May 2024 128 pages

Kyphoscoliosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major kyphoscoliosis markets are expected to exhibit a CAGR of 2.74% during 2024-2034. The kyphoscoliosis market has been comprehensively analyzed in IMARC's new report titled 'Kyphoscoliosis Ma...

May 2024 133 pages

Laband Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Laband syndrome markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.99%...

May 2024 134 pages

Lactose Intolerance Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lactose intolerance markets reached a value of US$ 10.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 20.9 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 139 pages

LAG 3 Next Generation Immunotherapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major LAG 3 next generation immunotherapy markets reached a value of US$ 370.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,403.0 Million by 2034, exhibiting a gr...

May 2024 129 pages

Lambert-Eaton Myasthenic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Lambert-Eaton myasthenic syndrome markets are expected to exhibit a CAGR of 5.15% during 2024-2034. The Lambert-Eaton myasthenic syndrome market has been comprehensively analyzed in IMARC'...

May 2024 137 pages

Lamellar Ichthyosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lamellar ichthyosis markets reached a value of US$ 5.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.1 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 136 pages

Langerhans Cell Histiocytosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Langerhans cell histiocytosis market reached a value of US$ 406.7 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 683.9...

May 2024 134 pages

Large Granular Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major large granular lymphocytic leukemia markets reached a value of US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 24.5 Billion by 2034, exhibiting a growth...

May 2024 132 pages

Laron Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major laron syndrome markets reached a value of US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% d...

May 2024 130 pages

Laryngeal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major laryngeal cancer markets reached a value of US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.46%...

May 2024 128 pages

Lassa Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Lassa fever markets are expected to exhibit a CAGR of 3.69% during 2024-2034. The Lassa fever market has been comprehensively analyzed in IMARC's new report titled 'Lassa Fever Market: Epi...

May 2024 138 pages

Leber Congenital Amaurosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Leber congenital amaurosis markets are expected to exhibit a CAGR of 3.23% during 2024-2034. The Leber congenital amaurosis market has been comprehensively analyzed in IMARC's new report t...

May 2024 134 pages

Leigh Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major leigh syndrome markets reached a value of US$ 105.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 175.1 Million by 2034, exhibiting a growth rate (CAGR) of 4.7...

May 2024 130 pages

Leiomyosarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major leiomyosarcoma markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The leiomyosarcoma market has been comprehensively analyzed in IMARC's new report titled 'Leiomyosarcoma Mar...

May 2024 138 pages

Leishmaniasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major leishmaniasis markets are expected to exhibit a CAGR of 6.38% during 2024-2034. The leishmaniasis market has been comprehensively analyzed in IMARC's new report titled 'Leishmaniasis Marke...

May 2024 129 pages

Lenegre’s Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Lenegre’s disease markets reached a value of US$ 782.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,569.6 Million by 2034, exhibiting a growth rate (CAGR) o...

May 2024 140 pages

Lennox-Gastaut Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Lennox-Gastaut syndrome markets are expected to exhibit a CAGR of 4.63% during 2024-2034. The Lennox-Gastaut syndrome market has been comprehensively analyzed in IMARC's new report titled...

May 2024 128 pages

Leukocyte Adhesion Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major leukocyte adhesion deficiency markets are expected to exhibit a CAGR of 5.11% during 2024-2034. The leukocyte adhesion deficiency market has been comprehensively analyzed in IMARC's new re...

May 2024 131 pages

Leukocyte Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major leukocyte disorders markets reached a value of US$ 57.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 89.6 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Leukopenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major leukopenia markets reached a value of US$ 10.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.53% dur...

May 2024 140 pages

Lice Infestation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lice infestation markets are expected to exhibit a CAGR of 4.57% during 2024-2034. The lice infestation market has been comprehensively analyzed in IMARC's new report titled 'Lice Infestat...

May 2024 128 pages

Lichen Planus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lichen planus markets reached a value of US$ 91.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 139.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.95%...

May 2024 134 pages

Lip and Oral Cavity Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lip and oral cavity cancer markets are expected to exhibit a CAGR of 3.56% during 2024-2034. The lip and oral cavity cancer market has been comprehensively analyzed in IMARC's new report t...

May 2024 136 pages

Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lipodystrophy markets are expected to exhibit a CAGR of 4.45% during 2024-2034. The lipodystrophy market has been comprehensively analyzed in IMARC's new report titled 'Lipodystrophy Marke...

May 2024 139 pages

Listeriosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major listeriosis markets are expected to exhibit a CAGR of 4.08% during 2024-2034. The listeriosis market has been comprehensively analyzed in IMARC's new report titled 'Listeriosis Market: Epi...

May 2024 129 pages

Liver Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major liver fibrosis markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.39% d...

May 2024 132 pages

Long QT Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major long QT syndrome markets are expected to exhibit a CAGR of 5.1% during 2024-2034. The long QT syndrome market has been comprehensively analyzed in IMARC's new report titled 'Long QT Syndro...

May 2024 138 pages

Low Back Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major low back pain markets are expected to exhibit a CAGR of 3.7% during 2024-2034. The low back pain market has been comprehensively analyzed in IMARC's new report titled 'Low Back Pain Market...

May 2024 130 pages

Low Grade Serous Ovarian Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major low grade serous ovarian carcinoma markets reached a value of US$ 179.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 363.7 Million by 2034, exhibiting a growt...

May 2024 136 pages

Lower-Limb Spasticity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lower-limb spasticity markets are expected to exhibit a CAGR of 6.98% during 2024-2034. The lower-limb spasticity market has been comprehensively analyzed in IMARC's new report titled 'Low...

May 2024 130 pages

Lumbar Spondylolisthesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lumbar spondylolisthesis markets are expected to exhibit a CAGR of 3.61% during 2024-2034. The lumbar spondylolisthesis market has been comprehensively analyzed in IMARC's new report title...

May 2024 140 pages

Lung Adenocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lung adenocarcinoma markets reached a value of US$ 14.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 27.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 129 pages

Lupus Nephritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lupus nephritis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.45%...

May 2024 134 pages

Lyme Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Lyme disease market reached a value of US$ 594.1 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 1,181.7 Mill...

May 2024 133 pages

Lymphadenopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphadenopathy markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The lymphadenopathy market has been comprehensively analyzed in IMARC's new report titled 'Lymphadenopathy...

May 2024 132 pages

Lymphangioleiomyomatosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphangioleiomyomatosis markets reached a value of US$ 87.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 125.5 Million by 2034, exhibiting a growth rate (CAG...

May 2024 135 pages

Lymphedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphedema markets reached a value of US$ 647.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,405.7 Million by 2034, exhibiting a growth rate (CAGR) of 7.3%...

May 2024 133 pages

Lymphoproliferative Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major lymphoproliferative disorders markets are expected to exhibit a CAGR of 7.32% during 2024-2034. The lymphoproliferative disorders market has been comprehensively analyzed in IMARC's new re...

May 2024 140 pages

Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Macular Edema market reached a value of US$ 3.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 5.8 Billion b...

May 2024 132 pages

Macular Telangiectasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major macular telangiectasia markets are expected to exhibit a CAGR of 6.7% during 2024-2034. The macular telangiectasia market has been comprehensively analyzed in IMARC's new report titled 'Ma...

May 2024 134 pages

Major Depressive Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The top 7 major depressive disorder markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.1 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 131 pages

Malignant Fibrous Histiocytoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malignant fibrous histiocytoma markets are expected to exhibit a CAGR of 8.67% during 2024-2034. The malignant fibrous histiocytoma market has been comprehensively analyzed in IMARC's new...

May 2024 133 pages

Malignant Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malignant mesothelioma markets reached a value of US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.2 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 135 pages

Malignant Pleural Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malignant pleural mesothelioma markets reached a value of US$ 318.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 632.6 Million by 2034, exhibiting a growth ra...

May 2024 137 pages

MALT Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major malt lymphoma markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 7.98% du...

May 2024 129 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...